Antibiotic prophylaxis may be still required among transperineal prostate biopsies of diabetics: a cohort study
1Department of Urological Surgery, Xiangshan County First People's Hospital Medical Health Group, Zhejiang, China.
Background:
Transperineal prostate biopsy (TP-PB) is considered the gold standard for suspected prostate cancer patients. However, the rate of transperineal prostate biopsy-related urinary tract infections (UTIs) has been calculated to be as high as 3%. This study aimed to discuss the incidence of transperineal prostate biopsy -related infections among diabetic patients who underwent antibiotic prophylaxis (AP) or not.
Methods:
The monocentric, comparative, observational cohort study was carried out at Xiangshan County First People's Hospital Medical Health Group, China between January 2021 and January 2023. The study included 246 diabetic men suspected of having prostate cancer who underwent transperineal prostate biopsy. One group was transperineal prostate biopsy with no antibiotic prophylaxis (Group A-no AP, n = 120, 48.8%), and the other was given a 3 days of oral antibiotics (Group B-AP, n = 126, 51.2%). Data on primary symptoms, urine culture (UC), urinary tract infections incidence, and prostate biopsy -related sequela were gathered 2 weeks following the prostate biopsy.
Results:
A total of 246 patients were involved, including 120 in Group A (67.4 ± 7.2 years) and 126 in Group B (68.5 ± 7.0 years) (p = 0.215). Prostate-specific antigen (PSA) levels were 16.1 ± 23.8 vs. 15.9 ± 22.3 ng/ml (p = 0.942), and the prostate cancer detection rate was 58% vs. 57.5% (p = 0.847). The incidence of asymptomatic bacteriuria was significantly higher (8/120, 6.7%) in Group A vs. Group B (1/126, 0.8%) (RR 8.4, 95% CI: 1.1-72.5, p < 0.001). Similarly, urinary irritation symptoms occurred in 30/120 (25.0%) vs. 5/126 (4.0%) patients (RR 6.3, 95% CI: 3.0-21.6, p < 0.001), fever in 9/120 (7.5%) vs. 1/126 (0.8%) (RR 9.5, 95% CI: 1.3-81.3, p = 0.001), and UTIs in 5/120 (4.2%) vs. 1/126 (0.8%) (RR 5.3, 95% CI: 0.63-47.2, p = 0.001), respectively. Notably, sepsis was not detected in either group.
Conclusion:
Antibiotic prophylaxis could decrease the incidence of transperineal prostate biopsy-related infections among diabetic patients.
Insights
Antibiotic prophylaxis significantly reduced urinary tract infections and related symptoms in diabetic patients undergoing transperineal prostate biopsy. This preventive measure is crucial for improving patient outcomes after the procedure.
Area of Science:
- Urology
- Infectious Diseases
- Oncology
Background:
- Transperineal prostate biopsy (TP-PB) is a standard procedure for diagnosing prostate cancer.
- TP-PB carries a risk of urinary tract infections (UTIs), with reported rates up to 3%.
- Diabetic patients may be at increased risk for infections following invasive procedures.
Purpose of the Study:
- To investigate the incidence of TP-PB-related infections in diabetic patients.
- To compare infection rates between diabetic patients who received antibiotic prophylaxis (AP) and those who did not.
Main Methods:
- A monocentric, comparative, observational cohort study included 246 diabetic men undergoing TP-PB.
- Patients were divided into two groups: no antibiotic prophylaxis (n=120) and 3-day oral antibiotic prophylaxis (n=126).
- Data collected included symptoms, urine cultures, UTI incidence, and biopsy-related sequelae within two weeks post-biopsy.
Main Results:
- The group receiving antibiotic prophylaxis showed significantly lower rates of asymptomatic bacteriuria (0.8% vs. 6.7%), urinary irritation symptoms (4.0% vs. 25.0%), fever (0.8% vs. 7.5%), and UTIs (0.8% vs. 4.2%) compared to the no-AP group.
- No cases of sepsis were reported in either group.
- Prostate-specific antigen levels and prostate cancer detection rates were similar between the groups.
Conclusions:
- Antibiotic prophylaxis is effective in reducing the incidence of transperineal prostate biopsy-related infections in diabetic patients.
- The findings support the use of AP to mitigate infection risks associated with TP-PB in this patient population.
Related Concept Videos
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Acute Pyelonephritis II: Diagnostic Studies and Management
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...


